NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 324 filers reported holding NEOGENOMICS INC in Q3 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,550,666 | -27.9% | 776,477 | -5.8% | 0.00% | -25.0% |
| Q2 2023 | $13,240,728 | -21.7% | 823,941 | -15.2% | 0.00% | -33.3% |
| Q1 2023 | $16,911,449 | +48.0% | 971,364 | -21.5% | 0.01% | +50.0% |
| Q4 2022 | $11,428,000 | +6.4% | 1,236,882 | -0.9% | 0.00% | 0.0% |
| Q3 2022 | $10,744,000 | +100.3% | 1,247,715 | +89.6% | 0.00% | +100.0% |
| Q2 2022 | $5,363,000 | -72.0% | 658,020 | -58.2% | 0.00% | -66.7% |
| Q1 2022 | $19,122,000 | -75.9% | 1,573,996 | -32.4% | 0.01% | -72.7% |
| Q4 2021 | $79,406,000 | -30.8% | 2,327,262 | -2.1% | 0.02% | -40.5% |
| Q3 2021 | $114,688,000 | +2.3% | 2,377,412 | -4.2% | 0.04% | +5.7% |
| Q2 2021 | $112,129,000 | +26.3% | 2,482,304 | +34.8% | 0.04% | +16.7% |
| Q1 2021 | $88,777,000 | -5.1% | 1,840,865 | +6.0% | 0.03% | -9.1% |
| Q4 2020 | $93,541,000 | +54.6% | 1,737,409 | +5.9% | 0.03% | +32.0% |
| Q3 2020 | $60,524,000 | +26.7% | 1,640,653 | +6.4% | 0.02% | +25.0% |
| Q2 2020 | $47,768,000 | +145.6% | 1,541,962 | +117.4% | 0.02% | +100.0% |
| Q1 2020 | $19,453,000 | -2.4% | 709,428 | +4.1% | 0.01% | +25.0% |
| Q4 2019 | $19,937,000 | +53.4% | 681,633 | +0.3% | 0.01% | +33.3% |
| Q3 2019 | $12,993,000 | -2.0% | 679,545 | +12.4% | 0.01% | 0.0% |
| Q2 2019 | $13,259,000 | +24.6% | 604,340 | +16.2% | 0.01% | +20.0% |
| Q1 2019 | $10,639,000 | +968.2% | 519,975 | +558.6% | 0.01% | – |
| Q4 2018 | $996,000 | +16.8% | 78,951 | +21.3% | 0.00% | – |
| Q2 2018 | $853,000 | -36.6% | 65,080 | -60.3% | 0.00% | -100.0% |
| Q3 2016 | $1,346,000 | -14.8% | 163,849 | -16.6% | 0.00% | 0.0% |
| Q2 2016 | $1,580,000 | -16.8% | 196,473 | -30.2% | 0.00% | 0.0% |
| Q1 2016 | $1,898,000 | +2.8% | 281,526 | +20.0% | 0.00% | 0.0% |
| Q4 2015 | $1,847,000 | +30683.3% | 234,691 | +11348.3% | 0.00% | – |
| Q3 2013 | $6,000 | -25.0% | 2,050 | 0.0% | 0.00% | – |
| Q2 2013 | $8,000 | – | 2,050 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
| Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
| First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
| PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
| EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
| Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
| FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
| OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
| Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |